KCNQ2/KCNQ3 potassium channel activators (University of Pittsburgh)

N/A

Report date: 2025/03/20 15:50:28
NME

Base Information

Drug NameKCNQ2/KCNQ3 potassium channel activators (University of Pittsburgh)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium voltage-gated channel subfamily KQT member 3 stimulantsVoltage-gated potassium channel subunit Kv7.2 agonists
TargetsPotassium voltage-gated channel subfamily KQT member 3Voltage-gated potassium channel subunit Kv7.2
Therapy Area/IndicationsTinnitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Pittsburgh
Inactive CompaniesN/A
Active IndicationsTinnitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A